LEXIA provided legal advice to Genenta Science, an Italian company listed on Nasdaq, in a significant $15 million registered direct offering transaction. The legal team, led by Managing Partner Francesco Dagnino and comprising Partners Giacomo Paracchi and Andrea Massimo Maroni, along with Associate Gabriel Zurlo Sconosciuto, supported Genenta in the issuance of new American Depositary Shares (ADS) to certain U.S. institutional investors.
The transaction included the filing of a supplement to the previously filed base prospectus with the U.S. Securities and Exchange Commission (SEC), which had been declared effective by the SEC. Thanks to the expertise and competence of our team, the operation was smoothly executed in compliance with U.S. regulations, reinforcing the strength of our approach in international equity capital markets transactions.
Full article on Legalcommunity >
